Rivaroxaban

동의어

1. BAY 59-7939, Xarelto, 5-Chloro-N-({(5S)-3-oxo-4-[2-oxo-2-(pyridin-2-yl)ethyl]-2,3,4,5-tetrahydro-1,2,4-triazin-5-yl}methyl)thiophene-2-carboxamide

Rivaroxaban is an oral anticoagulant that directly inhibits Factor Xa, a key enzyme in the coagulation cascade. It is widely used for the prevention and treatment of thromboembolic disorders, including deep vein thrombosis and pulmonary embolism. Our high-purity Rivaroxaban (CAS 366789-02-8) is manufactured under strict quality control, ensuring batch-to-batch consistency and compliance with international standards.

We supply Rivaroxaban in pharmaceutical grade, ideal for formulation development and commercial production. With competitive pricing and reliable global logistics, we support your supply chain from R&D to large-scale manufacturing. Contact us for detailed specifications and bulk quotations.

함수

• Anticoagulant: Direct Factor Xa inhibitor, providing effective and predictable anticoagulation.
• Thrombosis Prevention: Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
• Post-Surgical Care: Prevents venous thromboembolism after elective hip or knee replacement surgery.
• Treatment: Used for the treatment of DVT and PE, and for the prevention of recurrent DVT and PE.

문서 및 공급

• 문서: COA, MSDS
• 리드 타임: In stock for immediate dispatch; bulk orders typically ship within 7-10 days.
• 포장: Available in 1kg, 5kg, 25kg drums, or custom packaging upon request.

견적 요청

• 주소: 중국 산시성 시안시 메인 스트리트 280번지
• LyvBio 주식회사. — 이메일: info@lyvbio.com